NO20082534L - Andvendelse av pyroglutaminsyreestere som gasshydratinhibitorer med forbedret biotilgjengelighet - Google Patents

Andvendelse av pyroglutaminsyreestere som gasshydratinhibitorer med forbedret biotilgjengelighet

Info

Publication number
NO20082534L
NO20082534L NO20082534A NO20082534A NO20082534L NO 20082534 L NO20082534 L NO 20082534L NO 20082534 A NO20082534 A NO 20082534A NO 20082534 A NO20082534 A NO 20082534A NO 20082534 L NO20082534 L NO 20082534L
Authority
NO
Norway
Prior art keywords
pyroglutamic acid
acid esters
gas hydrate
improved bioavailability
hydrate inhibitors
Prior art date
Application number
NO20082534A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Feustel
Dirk Leinweber
Original Assignee
Clariant Produkte Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant Produkte Deutschland filed Critical Clariant Produkte Deutschland
Publication of NO20082534L publication Critical patent/NO20082534L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K8/00Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
    • C09K8/52Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
NO20082534A 2005-11-12 2008-06-06 Andvendelse av pyroglutaminsyreestere som gasshydratinhibitorer med forbedret biotilgjengelighet NO20082534L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005054037A DE102005054037A1 (de) 2005-11-12 2005-11-12 Verwendung von Pyroglutaminsäureestern als Gashydratinhibitoren mit verbesserter biologischer Abbaubarkeit
PCT/EP2006/010455 WO2007054226A1 (de) 2005-11-12 2006-10-31 Verwendung von pyroglutaminsäureestern als gashydratinhibitoren mit verbesserter biologischer abbaubarkeit

Publications (1)

Publication Number Publication Date
NO20082534L true NO20082534L (no) 2008-06-06

Family

ID=37507684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082534A NO20082534L (no) 2005-11-12 2008-06-06 Andvendelse av pyroglutaminsyreestere som gasshydratinhibitorer med forbedret biotilgjengelighet

Country Status (8)

Country Link
US (1) US8735332B2 (pt)
EP (1) EP1951841B1 (pt)
CN (1) CN101331205A (pt)
BR (1) BRPI0618445A2 (pt)
DE (2) DE102005054037A1 (pt)
ES (1) ES2342324T3 (pt)
NO (1) NO20082534L (pt)
WO (1) WO2007054226A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005006421A1 (de) 2005-02-12 2006-08-24 Clariant Produkte (Deutschland) Gmbh Polymere und ihre Herstellung und Verwendung als Gashydratinhibitoren
US8224195B2 (en) 2006-12-12 2012-07-17 Oce Printing Systems Gmbh Method for controlling a development process in different operating phases
DE102007037015B3 (de) * 2007-08-06 2008-10-23 Clariant International Limited Verwendung von substituierten Polyethyleniminen als Gashydratinhibitoren mit verbesserter biologischer Abbaubarkeit
DE102007037016B4 (de) 2007-08-06 2011-06-30 Clariant International Limited Verwendung von 1-Alkyl-5-oxo-pyrrolidin-3-carbonsäureestern als Gashydratinhibitoren mit verbesserter biologischer Abbaubarkeit
DE102007037017A1 (de) * 2007-08-06 2009-02-19 Clariant International Ltd. 1-Alkyl-5-oxo-pyrrolidin-3-carbonsäureester mit verbesserter biologischer Abbaubarkeit
DE102010022759A1 (de) * 2010-06-04 2011-12-08 Clariant International Ltd. Additive zur Inhibierung der Gashydratbildung
US9840654B2 (en) * 2012-11-16 2017-12-12 Schlumberger Norge As Kinetic hydrate inhibitors with pendent amino functionality
CN104390138B (zh) * 2014-09-18 2017-07-14 中国海洋石油总公司 一种复配型气体水合物阻聚剂及其应用
BR112019027457A2 (pt) 2017-07-07 2020-07-07 Basf Se esteramina e sal da mesma, processo para preparação de esteramina ou sal da mesma, uso de esteramina e sal da mesma, e, composição de cuidados pessoais.
EP3823451A4 (en) * 2018-08-28 2022-05-04 Verdesian Life Sciences U.S., LLC EXTENDED AND CONTINUOUS RELEASE COMPOSITIONS FOR PLANT HEALTH AND METHODS OF USE
CN116082626A (zh) * 2023-02-13 2023-05-09 中国科学院长春应用化学研究所 一种焦谷氨酸改性增塑剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244878A (en) * 1987-12-30 1993-09-14 Institut Francais Du Petrole Process for delaying the formation and/or reducing the agglomeration tendency of hydrates
AU675227B2 (en) 1992-06-11 1997-01-30 Colorado School Of Mines A method for inhibiting gas hydrate formation
US5432292A (en) 1992-11-20 1995-07-11 Colorado School Of Mines Method for controlling clathrate hydrates in fluid systems
WO1994024413A1 (en) * 1993-04-08 1994-10-27 Bp Chemicals Limited Method for inhibiting solids formation and blends for use therein
EP0896123B1 (fr) * 1997-08-05 2005-07-27 Institut Français du Pétrole Procédé pour ralentir la croissance et/ou l'agglomération et éventuellement retarder la formation d'hydrates dans un effluent de production
DE19920152C1 (de) * 1999-05-03 2000-10-12 Clariant Gmbh Additive zur Inhibierung der Gashydratbildung und deren Verwendung
US6977311B2 (en) 2002-10-25 2005-12-20 Bionumerik Pharmaceuticals, Inc. Process for synthesizing L-γ-methylene glutamic acid and analogs
DE102005054038A1 (de) * 2005-11-12 2007-05-24 Clariant Produkte (Deutschland) Gmbh Pyroglutaminsäureester mit verbesserter biologischer Abbaubarkeit

Also Published As

Publication number Publication date
EP1951841B1 (de) 2010-05-26
ES2342324T3 (es) 2010-07-05
DE502006007058D1 (de) 2010-07-08
DE102005054037A1 (de) 2007-05-16
US20100213408A1 (en) 2010-08-26
EP1951841A1 (de) 2008-08-06
BRPI0618445A2 (pt) 2011-08-30
US8735332B2 (en) 2014-05-27
WO2007054226A1 (de) 2007-05-18
CN101331205A (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
NO20082534L (no) Andvendelse av pyroglutaminsyreestere som gasshydratinhibitorer med forbedret biotilgjengelighet
WO2014099438A3 (en) Esterification of 2,5-furan-dicarboxylic acid
BRPI0803573A2 (pt) uso de ésteres 1-alquil-5-oxopirrolidina-3-carboxìlicos como inibidores de hidratos de gases com melhor biodegradabilidade
MY185428A (en) Self-emulsifying composition of ?-3 fatty acid
WO2007094922A3 (en) Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents
MX2009005397A (es) Proceso para la conversion de compuestos nitrilo en acidos carboxilicos y esteres correspondientes.
MX2009012867A (es) Proceso para preparar ácido metacrílico o ésteres metacrílicos.
WO2009095197A3 (de) Zusammensetzungen enthaltend phosphorsäureester und hydrophob modifizierte, vernetzte, anionische polymere
NZ597034A (en) Esterified lignocellulosic materials and methods for making them
NO20073889L (no) Fast farmasoytisk sammensetning omfattende Valsartan
WO2010011804A3 (en) Method of transitioning to kinetic hydrate inhibitors in multiple tie-in well systems
AU2012252847B2 (en) Rotating tower crane
ATE531769T1 (de) Verwendung von estern als koaleszenzmittel
BR112013000593A2 (pt) conversão de álcoois
WO2011157640A3 (en) A high humectant high internal phase emulsion
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
NO20072998L (no) Stabilisering av glukokortikoidestere med syrer
MX2009010483A (es) 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas.
BR112012014487A2 (pt) processo para inibir polimerização de ácido (met) acrílico e/ou ésteres (met) acrílicos
ATE547393T1 (de) Kontinuierliches verfahren zur gewinnung eines milchsäureesters
BR112013012947A2 (pt) uso de ésteres como agente de coalescência
WO2009011449A3 (en) Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
MX345199B (es) Limpiador sin agua con bajo contenido de cov y artículo impregnado con él.
WO2007054225A3 (de) Pyroglutaminsäureester mit verbesserter biologischer abbaubarkeit
WO2009150179A3 (en) Plant extract and pufa combinations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application